Viewing data from:

ESTAZOLAM

ANDA

ESTAZOLAM | A074818 | WATSON LABORATORIES INC

2 strengths0 unique patents0 unique exclusivities

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 2 NDCs

Highest NADAC/Unit

$0.8250

per ea

Lowest NADAC/Unit

$0.7861

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
00591074401ESTAZOLAM 1 MG TABLET	$0.8250	EA	Generic	—	2026-06-17
00591074501ESTAZOLAM 2 MG TABLET	$0.7861	EA	Generic	—	2026-06-17

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

API Supply Chain3 active DMFs1 inactive

3 active API suppliers hold Drug Master Files for this ingredient.

FIS FABBRICA ITALIANA SINTETICI SPAESTAZOLAM

DMF 117841995

CAMBREX PROFARMACO MILANO SRLESTAZOLAM

DMF 122281996

SS PHARMA LLCESTAZOLAM USP

DMF 386802023

TAKEDA CHEMICAL INDUSTRIES LTDInactiveESTAZOLAM (TA-8)

DMF 28591977

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (2)

Sort:

#001 — 1MG

0 patents0 exclusivities▴

TABLET;ORAL | Approved: Aug 19, 1997

No patent or exclusivity listings for this strength.

#002 — 2MG

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Aug 19, 1997